Background and Purpose-Very late antigen-4 (integrin ɑ4β1)/vascular cell adhesion molecule-1 mediates leukocyte trafficking and transendothelial migration after stroke. Mesenchymal stem cells (MSCs) typically express integrin β1 but insufficient ITGA4 (integrin ɑ4), which limits their homing after intravascular transplantation. We tested whether ITGA4 overexpression on MSCs increases cerebral homing after intracarotid transplantation and reduces MSC-borne cerebral embolism. Methods-Rat MSCs were lentivirally transduced to overexpress ITGA4. In vitro transendothelial migration was assessed using a Boyden chamber assay. Male Wistar rats intracarotidly received 0.5×10 6 control or modified MSCs 24 hours after sham or stroke surgery. In vivo behavior of MSCs in the cerebral vasculature was observed by intravital microscopy and single-photon emission computed tomography for up to 72 hours. Results-Transendothelial migration of ITGA4-overexpressing MSCs was increased in vitro. MSCs were passively entrapped in microvessels in vivo and occasionally formed large cell aggregates causing local blood flow interruptions. MSCs were rarely found in perivascular niches or parenchyma at 72 hours post-transplantation, but ITGA4 overexpression significantly decreased cell aggregation and ameliorated the evoked cerebral embolism in stroke rats. Conclusions-ITGA4 overexpression on MSCs enhances transendothelial migration in vitro, but not in vivo, although it improves safety after intracarotid transplantation into stroke rats. Visual Overview-An online visual overview is available for this article. 
M esenchymal stem cells (MSCs) transplantation is a promising emerging paradigm for stroke treatment. However, after intravenous infusion, most of the infused cells are trapped in filtering organs such as the lungs.
1 Intra-arterial infusion is more efficient, but MSCs still do not transmigrate efficiently into the cerebral parenchyma. Moreover, complications including cerebral embolism after intra-arterial MSC transplantation have been reported in both preclinical and clinical studies. 2 The interaction between VLA4 (very late antigen-4; integrin α 4 β 1 ) and VCAM1 (vascular cell adhesion molecule-1) is required for firm adhesion and transendothelial migration in leukocytes.
3 VLA4 is a cell adhesion molecule expressed on leukocyte plasma membranes. It binds to VCAM1, which is overexpressed on cerebral endothelial cells after stroke. 4 MSCs typically express integrin β1, a subunit of VLA4, but insufficient amounts of ITGA4 (integrin α4) 5 ; this may limit their homing abilities. We tested the hypothesis whether ITGA4 overexpression on MSCs could (1) enhance their cerebral homing after intracarotid transplantation into stroke rats and (2) decrease the cell-evoked cerebral embolism by reducing the disturbance to cerebral blood flow.
Materials and Methods
Full description of the Methods including the experimental design ( Figure I in the online only Data Supplement) can be found in the online only Data Supplement.
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Cell Culture
Cryopreserved bone marrow-derived MSCs from Wistar rats (Cat. No. RAWMX-01001; Cyagen Biosciences) were thawed and expanded in growth medium (KnockOut DMEM/F-12; Life Technologies) supplemented with 1% GlutaMAX, 7.5% fetal bovine serum, and 1% penicillin/streptomycin at 37°C under 5% O 2 and 5% CO 2 . Cells at no later than passage 8 were used.
Cell Modification
Lentiviral vectors carrying rat ITGA4-cDNA sequence were transferred to MSC monolayer for 24-hour incubation. ITGA4-positive clones were sorted using flow cytometry (BD FACS-ARIA) and expanded thereafter.
In Vitro Transmigration Assay
The transendothelial migration capacities of MSCs were assessed using a modified Boyden chamber setup.
Cell Aggregate Quantification by Flow Cytometry
The flow cytometry-based pulse-width assay was used to quantify cell aggregates (>30 µm) in suspension under the same conditions (concentration, media, and temperature) as those transplanted into rats. 6 The samples were run on FACS Canto II flow cytometer (BD Biosciences), and 50 000 events were collected from each sample.
Animals
Adult male RccHan Wistar rats were used according to the European Community Council Directives 86/609/EEC guidelines, and all procedures were approved by the National Animal Experiment Board (Hämeenlinna, Finland).
Stroke Model and Cell Transplantation
Focal cerebral ischemia was induced by transient middle cerebral artery occlusion using a filament. The filament was not inserted in sham-operated rats. The cells were transplanted 24 hours after stroke because this is the most commonly applied time window for cell transplantation, 7, 8 and furthermore, the expression of VCAM1 peaks at this time point. 4, 9 Because the risk of cell-evoked cerebral embolism is increased with higher cell doses, 10 a total of 0.5×10 6 nonmodified (CTRL) or modified (ITGA4) MSCs were injected from the external carotid artery as a compromise between safety and in vivo cell visibility.
Intravital Microscopy
Animals were imaged with the FV1000MPE 2-photon microscope (Olympus, Japan) after cranial window preparation. Fluorescein isothiocyanate dextran (MW = 2000 kDa; Sigma) was injected to visualize the vasculature, and MSCs were prelabeled with DiD (Life Technologies) to increase visibility. Imaging was performed during and at up to 72 hours after cell transplantation because cell homing should occur within this time period.
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Statistical Analysis
Two-tailed Student t test or 2-way ANOVA followed by Bonferroni post hoc correction was performed using SPSS software 19.0. Data are presented as mean±SD.
Results
ITGA4 Overexpression Increases Transendothelial Migration In Vitro
Lentiviral transduction and sorting resulted in robust ITGA4 protein expression ( Figure 1A ) and a significantly higher mRNA level of ITGA4 (P<0.05 versus CTRL-MSCs; 
ITGA4 Overexpression Does Not Increase Transendothelial Migration In Vivo
After transplantation, DiD-labeled MSCs (average diameter ≈18 µm for both CTRL-and ITGA4-MSCs) were found entrapped inside microvessels (diameter, 5-10 µm; Figure 2A and 2B). MSC quantification in the brain 2 hours after transplantation was not different between CTRL-and ITGA4-MSCs ( Figure 2C ). Remaining MSCs were still inside the cerebral vasculature at 24 or 72 hours post-transplantation ( Figure 2D 
ITGA4 Overexpression Reduces MSC Aggregation and Cerebral Embolism
Cell aggregates (>30 µm) were observed under the 2-photon microscope ( Figure 3A ) in 5 rats after CTRL-MSCs transplantation and in 1 rat after ITGA4-MSCs transplantation. CTRL-MSCs transplantation into stroke rats decreased cerebral blood flow dramatically as compared with ITGA4-MSCs (P<0.05) and caused larger lesions (P<0.05; Figure 3B ). Flow cytometry revealed more cell aggregates >30 μm in the CTRL-MSC suspension (P<0.01; Figure 3C ). Histology revealed vascular MSC entrapment in those micro-occlusions ( Figure 3D ). Four rats died after CTRL-MSCs transplantation, and 1 rat died after ITGA4-MSCs transplantation.
Discussion
We observed a MCP1-dependent transmigration of CTRLMSCs across the tumor necrosis factor alpha (TNFα)-activated rat cerebral endothelial monolayer in vitro. MCP1 is involved in leukocyte trafficking and migration. It is upregulated after an ischemic insult 12 and can activate VLA4. 13 ITGA4 overexpression enhances MSC migration, indicating a more efficient interaction between MSCs and activated endothelium, and subsequent transmigration.
Our in vivo results indicate that passive entrapment because of the large cell size plays a major role in the initial arrest of MSCs in the cerebral vasculature after intracarotid administration. This is in line with previous findings that arterially delivered MSCs are mechanically trapped at the precapillary level in the peripheral vasculature, 11 causing microembolisms. Cell aggregates blocking larger arteries were also observed, providing direct evidence that cerebral embolism after arterial MSC transplantation is based on passive vascular entrapment. Fewer cell aggregates and, consequently, less vascular embolism and reduced mortality were observed after ITGA4-MSCs transplantation. Potential reasons are the altered aggregation properties in the cell suspension after ITGA4 overexpression 14 or a difference in the instantaneous blood-mediated inflammatory reaction between CTRL-and ITGA4-MSCs. Indeed, culture-expanded MSCs can trigger procoagulatory cascades via the surface expression of prothrombotic factors. 15 No evidence of increased transmigration of ITGA4-MSCs was seen in vivo, perhaps because MSC adhesion to endothelium is not strong enough to withstand blood flow shear stress. A lack of VCAM1 expression at the time point of ITGA4-MSCs transplantation was not evident (Figure VII in online-only Data Supplement), but additional expression of other key molecules may be required to modify this complex homing cascade. 16 Our study has some limitations. First, the sample size per group is relatively small, but still acceptable as this is an exploratory study only meant to reveal the most robust effects. Second, peripheral organs such as the spleen were not investigated in detail. Although the cells escaping from the brain would be trapped initially in the pulmonary capillaries, some might have passed through the lungs and entered the spleen. These organs should be investigated in future studies as they may mediate some relevant cell therapy effects. 17, 18 Third, the paradigm was not tested in female or aged subjects. This should be done in further studies as both factors are relevant with respect to stroke. [19] [20] [21] For instance, age and associated comorbidities such as hypertension and atherosclerosis alter the vascular constitution and may thereby influence the clotting frequency. In the future, an optimal protocol of MSC transplantation with 
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enhanced homing and reduced complications needs to be further established to facilitate its translation from bench to clinic.
